arterial catheter News
-
CTA approval for potentially pivotal Heartcel Phase IIb trial
Adult heart failure trial to complete in 2020 with potential market entry in 2021 Trial to be conducted at Imperial College London’s Royal Brompton, UK Celixir, a private company discovering and developing lifesaving regenerative medicines, today announced it has received formal clinical trial application (CTA) approval from the Medicines and Healthcare Products Regulatory Agency to ...
By Celixir plc
-
Biomodex Teams Up with Physicians at Three of the World’s Top Medical Centers to Develop a Cutting-Edge Training Solution for Treatment of Ischemic Stroke
BIOMODEX, a pioneering digital health company that offers a unique and enhanced 3D printed solution for physician training, announced today the company has partnered with two of the top medical centers in France and a world-class health system in the United States to develop EVIAS Plus - an innovative training solution for treatment of ischemic stroke. Ischemic stroke accounts for about 87 ...
By BIOMODEX
-
Concept Medical is Granted CE Certification for Sirolimus Coated MagicTouch Group of Products.
Concept Medical B.V. with its headquarters in Tampa, Florida has announced that on 16th October 2019, they have received the CE certification for their MagicTouch group of products. The CE certified products/brands are as listed below: MagicTouch – PTA (Sirolimus Coated PTA Balloon Catheter) for peripheral arterial disease MagicTouch – ED (Sirolimus Coated Balloon Catheter) for ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you